MAXF1 is a venture capital platform focused on early-stage technology companies with a global investment strategy. The fund targets a $250M commitment and focuses on AI, fintech, health technology and other transformative sectors.
Seed to Series A investments supported by AI-assisted due diligence, global sourcing and active portfolio management.
Fund materials are intended for qualified purchasers and accredited investors. See the investment deck for further information.